Sign Up to like & get
recommendations!
0
Published in 2019 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14683
Abstract: (R)‐Ketamine (arketamine) may have utility as a rapidly acting antidepressant. While (R)‐ketamine has lower potency than (R,S)‐ketamine to inhibit NMDA receptors in vitro, the extent to which (R)‐ketamine shares the NMDA receptor‐mediated adverse effects of…
read more here.
Keywords:
ketamine;
antidepressant actions;
exerts antidepressant;
ketamine exerts ... See more keywords